Mechanisms of obesity-induced hypertension

被引:0
|
作者
Vasilios Kotsis
Stella Stabouli
Sofia Papakatsika
Zoe Rizos
Gianfranco Parati
机构
[1] Hypertension Center,3rd Department of Medicine
[2] Papageorgiou Hospital,Department of Clinical Medicine and Prevention
[3] Aristotle University of Thessaloniki,undefined
[4] Pediatric Intensive Care Unit,undefined
[5] Hippokration Hospital,undefined
[6] University of Toronto,undefined
[7] University of Milano-Bicocca,undefined
[8] Deptartment of Cardiology,undefined
[9] S. Luca Hospital,undefined
[10] Istituto Auxologico Italiano,undefined
来源
Hypertension Research | 2010年 / 33卷
关键词
leptin; obesity; pressure natriuresis; rennin–angiotensin–aldosterone system; sympathetic nervous system;
D O I
暂无
中图分类号
学科分类号
摘要
The relationship between obesity and hypertension is well established both in children and adults. The mechanisms through which obesity directly causes hypertension are still an area of research. Activation of the sympathetic nervous system has been considered to have an important function in the pathogenesis of obesity-related hypertension. The arterial-pressure control mechanism of diuresis and natriuresis, according to the principle of infinite feedback gain, seems to be shifted toward higher blood-pressure levels in obese individuals. During the early phases of obesity, primary sodium retention exists as a result of increase in renal tubular reabsorption. Extracellular-fluid volume is expanded and the kidney-fluid apparatus is resetted to a hypertensive level, consistent with a model of hypertension because of volume overload. Plasma renin activity, angiotensinogen, angiotensin II and aldosterone values display significant increase during obesity. Insulin resistance and inflammation may promote an altered profile of vascular function and consequently hypertension. Leptin and other neuropeptides are possible links between obesity and the development of hypertension. Obesity should be considered as a chronic medical condition, which is likely to require long-term treatment. Understanding of the mechanisms associated with obesity-related hypertension is essential for successful treatment strategies.
引用
收藏
页码:386 / 393
页数:7
相关论文
共 50 条
  • [21] Leptin receptor downregulation in the carotid body treats obesity-induced hypertension
    Shin, Mi-Kyung
    Kim, Lenise J.
    Davaanyam, Dashdulam
    Amorim, Mateus R.
    Lee, Sean M.
    Tang, Wan-Yee
    Polotsky, Vsevolod Y.
    JOURNAL OF NEUROPHYSIOLOGY, 2025, 133 (03) : 892 - 903
  • [22] Adipocyte Deficiency of Angiotensinogen Prevents Obesity-Induced Hypertension in Male Mice
    Yiannikouris, Frederique
    Gupte, Manisha
    Putnam, Kelly
    Thatcher, Sean
    Charnigo, Richard
    Rateri, Debra L.
    Daugherty, Alan
    Cassis, Lisa A.
    HYPERTENSION, 2012, 60 (06) : 1524 - U382
  • [23] Oxidative stress in a rat model of obesity-induced hypertension
    Dobrian, AD
    Davies, MJ
    Schriver, SD
    Lauterio, TJ
    Prewitt, RL
    HYPERTENSION, 2001, 37 (02) : 554 - 560
  • [24] Mechanisms of Small Intestine Involvement in Obesity-Induced Atherosclerosis
    Pan, Xiaoyu
    Jia, Zhuoya
    Zhen, Ruoxi
    Yue, Lin
    Niu, Shu
    Ban, Jiangli
    Chen, Shuchun
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 1941 - 1952
  • [25] Mechanisms of Obesity-Induced Changes in Pharmacokinetics of IgG in Rats
    Gao, Xizhe
    Sheng, Yi-Hua
    Yu, Sijia
    Li, Jiadong
    Rosa, Raymond
    Girgis, Simone
    Guo, Tiffany
    Brunetti, Luigi
    Kagan, Leonid
    PHARMACEUTICAL RESEARCH, 2023, 40 (05) : 1223 - 1238
  • [26] Mechanisms of macrophage activation in obesity-induced insulin resistance
    Odegaard, Justin I.
    Chawla, Ajay
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (11): : 619 - 626
  • [27] Mechanisms of Obesity-Induced Changes in Pharmacokinetics of IgG in Rats
    Xizhe Gao
    Yi-Hua Sheng
    Sijia Yu
    Jiadong Li
    Raymond Rosa
    Simone Girgis
    Tiffany Guo
    Luigi Brunetti
    Leonid Kagan
    Pharmaceutical Research, 2023, 40 : 1223 - 1238
  • [28] OBESITY-INDUCED HYPERTENSION - RENAL-FUNCTION AND SYSTEMIC HEMODYNAMICS
    HALL, JE
    BRANDS, MW
    DIXON, WN
    SMITH, MJ
    HYPERTENSION, 1993, 22 (03) : 292 - 299
  • [29] Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration
    de Paula, RB
    da Silva, AA
    Hall, JE
    HYPERTENSION, 2004, 43 (01) : 41 - 47
  • [30] Cellular and Molecular Mechanisms and Effects of Berberine on Obesity-Induced Inflammation
    Noh, Ji-Won
    Jun, Min-Soo
    Yang, Hee-Kwon
    Lee, Byung-Cheol
    BIOMEDICINES, 2022, 10 (07)